Android app on Google Play

RBC Capital Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Underperform

February 7, 2013 6:56 AM EST Send to a Friend
Get Alerts ENDP Hot Sheet
Price: $63.71 -0.48%

Rating Summary:
    15 Buy, 11 Hold, 4 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 3 | Down: 4 | New: 7
Trade ENDP Now!
Join SI Premium – FREE
RBC Capital downgraded Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) from Sector Perform to Underperform with a price target of $24.00 (from $25.00).

For an analyst ratings summary and ratings history on Endo Pharmaceuticals Holdings Inc click here. For more ratings news on Endo Pharmaceuticals Holdings Inc click here.

Shares of Endo Pharmaceuticals Holdings Inc closed at $31.00 yesterday.




You May Also Be Interested In


Related Categories

Downgrades, Hot Downgrades

Related Entities

RBC Capital

Add Your Comment